Jeanette Wendt

Statistics

Publications

Citations

1.2K

H-Index

Active since

2005

Affiliations

Heinrich Heine University Düsseldorf(Current)

University of British Columbia

University of California, San Francisco

University of Cambridge

Merck KGaA, Darmstadt (Germany)

Jeanette Wendt is an author at Heinrich Heine University Düsseldorf specializing in pharmacotherapy, neurology, and multiple sclerosis pharmacotherapy.

Publications per year

2005–2020

Publications

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis

Amit Bar‐Or, Jonathan Calkwood, Cathy Chognot et al. · Neurology · 2020 · 339 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline

P. Murali Doraiswamy, Reisa A. Sperling, Robert E. Coleman et al. · Neurology · 2012 · 228 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.

Steven R. Schwid, John Thorpe, Mohammad K. Sharief et al. · PubMed · 2005 · 82 citations

Pharmacy, Neurology, Pharmacotherapy +14

Cladribine tablets added to IFN-β in active relapsing MS

Xavier Montalbán, Thomas Leist, Bruce A. Cohen et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 63 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 8